Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 8CNS 8Gastrointestinal 4Endocrine 4NET 3Thoracic 2Genitourinary 2Other solid neoplasm 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Dermatologic 1Breast 1

Conditions

Breast Neoplasms 6392Neoplasms 408Ovarian Neoplasms 308Triple Negative Breast Neoplasms 286Prostatic Neoplasms 280Lung Neoplasms 271Colorectal Neoplasms 255Neoplasm Metastasis 254Carcinoma, Non-Small-Cell Lung 221Breast Neoplasms, Male 201Colonic Neoplasms 168Motor Activity 166Pancreatic Neoplasms 164Melanoma 157Carcinoma, Intraductal, Noninfiltrating 139Stomach Neoplasms 128Uterine Cervical Neoplasms 127Head and Neck Neoplasms 124Fatigue 104Breast Carcinoma In Situ 103Carcinoma, Ovarian Epithelial 98Endometrial Neoplasms 96Lymphedema 95Carcinoma, Renal Cell 94Urinary Bladder Neoplasms 93Pain 90Sarcoma 89Small Cell Lung Carcinoma 85Lymphoma 83Esophageal Neoplasms 81

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neuroectodermal Tumors × Breast × Clear all
NCT00753415 2015-03-17

A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)

Merck Sharp & Dohme LLC

Phase 1 Completed
37 enrolled 10 charts
BreastDermatologicEndocrineGastrointestinalGenitourinaryNETThoracic

Adenocarcinoma, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Breast Diseases, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Genital Diseases, Male, Intestinal Neoplasms, Kidney Diseases, Kidney Neoplasms, Melanoma, Neoplasms, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Prostatic Diseases, Prostatic Neoplasms, Skin Diseases, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms, Colorectal Neoplasms, Neuroectodermal Tumors, Nevi and Melanomas, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡